| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.1B | $5.6B | $5.5B | $4.7B | $4.4B | $1.1B | $0.8B | $0.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.7B | $0.5B | $0.5B | $0.6B | $0.7B | $0.6B | $0.6B | $0.5B |
| Net Income | $1.3B | $0.6B | $0.9B | $0.4B | $1.7B | $0.1B | $0.3B | $0.1B |
| EPS (Basic) | $3.73 | $1.74 | $3.04 | $1.18 | $5.95 | $0.16 | $1.51 | $0.15 |
| EPS (Diluted) | $3.58 | $1.61 | $3.00 | $1.11 | $5.94 | $0.16 | $1.50 | $0.15 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $49.4B | $45.3B | $44.1B | $41.5B | $36.4B | $36.1B | $23.1B | $23.8B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $3.5B | $3.9B | $1.6B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Total Liabilities | $24.6B | $22.1B | $23.1B | $21.9B | $17.8B | $17.6B | $12.4B | $12.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $22.9B | $21.3B | $19.1B | $17.6B | $18.0B | $17.7B | $9.9B | $9.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.4B | $2.3B | $1.6B | $1.7B | $1.7B | $1.7B | $1.5B | $1.4B |
| Investing Cash Flow | $-2.2B | $-1.9B | $-1.1B | $-4.7B | $-1.1B | $-2.6B | $-0.3B | $-3.0B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.5B | $2.1B | $1.0B | $3.0B | $-0.6B | $0.9B | $-1.3B | $1.8B |